Shan-Shan Zhang, Niu-Niu Zhan, Tian-Tian Guo, Lee-Yan Sheen, Chi-Tang Ho, Nai-Sheng Bai


October 2022


Background and aim
Cannabis sativa L. is a medicinal plant with a long history. Phyto-cannabinoids are a class of compounds from C. sativa L. with varieties of structures. Endocannabinoids exist in the human body. This article provides an overview of natural cannabinoids (phyto-cannabinoids and endocannabinoids) with an emphasis on their pharmacology activities.

Experimental procedure
The keywords “Cannabis sativa L″, “cannabinoids”, and “central nervous system (CNS) diseases” were used for searching and collecting pieces of literature from PubMed, ScienceDirect, Web of Science, and Google Scholar. The data were extracted and analyzed to explore the effects of cannabinoids on CNS diseases.

Result and conclusion
In this paper, schematic diagrams are used to intuitively show the phyto-cannabinoids skeletons’ mutual conversion and pharmacological activities, with special emphasis on their relevant pharmacological activities on central nervous system (CNS) diseases. It was found that the endocannabinoid system and microglia play a crucial role in the treatment of CNS diseases. In the past few years, pharmacological studies focused on Δ9-THC, CBD, and the endocannabinoids system. It is expected to encourage new studies on a more deep exploration of other types of cannabinoids and the mechanism of their pharmacological activities in the future.


DOI: 10.1016/j.jtcme.2022.10.004


Zhang, S. S., Zhang, N. N., Guo, T. T., Sheen, L. Y., Ho, C. T., & Bai, N. S. (2022). The impact of phyto-and endo-cannabinoids on central nervous system diseases: A review. Journal of Traditional and Complementary Medicine.